Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
LYCOPODIUM LTD. | LW1 | Sep 20, 2024 | 7.05 | 0.00 |
LYCOS ENERGY INC. NEW | G4P0 | Sep 20, 2024 | 1.84 | -4.66 |
Lyft, Inc. - Class A | LY0 | Sep 20, 2024 | 11.09 | -0.23 |
Lynas Rare Earths Limited | LYI | Sep 20, 2024 | 4.21 | -1.86 |
Lynas Rare Earths Limited American Depositary Receipts - Spo | LYIC | Sep 20, 2024 | 4.10 | -0.97 |
LyondellBasell Industries NV Ordinary Shares Class A (Nether | DLY | Sep 20, 2024 | 85.34 | +1.38 |
Lytix Biopharma | 6BG | Sep 20, 2024 | 0.62 | +0.32 |
L`Oreal | LORA | Sep 20, 2024 | 75.00 | 0.00 |
M Vest Water | 7YA | Sep 20, 2024 | 0.81 | -1.23 |
M&C Saatchi | IZH | Sep 20, 2024 | 2.26 | -0.88 |
M&G | 7MP | Sep 20, 2024 | 2.47 | -2.14 |
M&T Bank Corporation | MTZ | Sep 20, 2024 | 160.20 | +2.36 |
M.P. Evans Group Plc | NYP | Sep 20, 2024 | 10.60 | +1.92 |
M/I Homes, Inc. | 4MI | Sep 20, 2024 | 153.00 | -1.10 |
M1 Kliniken AG | M12 | Sep 20, 2024 | 18.00 | +2.27 |
M3, Inc. | 4YC | Sep 20, 2024 | 8.75 | -0.57 |
MAANSHAN IRON | YM9A | Sep 20, 2024 | 0.09 | -8.76 |
Maat Pharma S.A. | 4RD | Sep 20, 2024 | 6.94 | +3.58 |
Mabion S.A. | 272 | Sep 20, 2024 | 3.83 | -1.16 |
Mabuchi Motor Co. Ltd. | V94 | Sep 20, 2024 | 13.30 | -0.75 |
Macarthur Minerals Ltd | MMLA | Sep 20, 2024 | 0.02 | -7.14 |
Macerich Company (The) | M6G | Sep 20, 2024 | 15.08 | +0.63 |
MacFarlane Group plc | 5K6 | Sep 20, 2024 | 1.27 | -3.79 |
Mack-Cali Realty Corporation | WY4 | Sep 20, 2024 | 15.80 | -1.25 |
MACOM Technology Solutions Holdings, Inc. | 1MA | Sep 20, 2024 | 93.00 | -1.06 |
MACQUARIE GROUP ADR 1 | 4M42 | Sep 20, 2024 | 135.00 | 0.00 |
Macquarie Group Ltd Ordinary shares (Australia) | 4M4 | Sep 20, 2024 | 142.18 | +1.10 |
MACQUARIE GRP DEF. CNS 3 | 4M41 | Sep 20, 2024 | 52.00 | 0.00 |
MacroGenics, Inc. | M55 | Sep 20, 2024 | 2.99 | -1.91 |
Macromill, Inc. | MA5 | Sep 20, 2024 | 4.80 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.